Serato, Jave Akiro A.

HRN: 27-51-85  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/08/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/08/2025
08/14/2025
IVT
23mg
Q24
T/C Neonatal Sepsis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Unspecified Sepsis    Compliance to guidelines: